NEOP - Neoprobe Corp.

Neoprobe Corporation (Neoprobe) is a biomedical company that develops and commercializes oncology products. The Company markets a range of medical devices, its neoprobe gamma detection systems (GDS). In addition to ITS medical device products, it has two radiopharmaceutical products, Lymphoseek and RIGScan CR, in advanced phases of clinical development. Neoprobe also focuses to explore the development of its activated cellular therapy (ACT) technology for patient-specific disease treatment through it subsidiary, Cira Biosciences, Inc. (Cira Bio).